Next Article in Journal
Coexpression and Secretion of Endoglucanase and Phytase Genes in Lactobacillus reuteri
Next Article in Special Issue
Abnormal Unsaturated Fatty Acid Metabolism in Cystic Fibrosis: Biochemical Mechanisms and Clinical Implications
Previous Article in Journal
Antibacterial Effect of Dental Adhesive Containing Dimethylaminododecyl Methacrylate on the Development of Streptococcus mutans Biofilm
Previous Article in Special Issue
Impact of Inhaled Nitric Oxide on the Sulfatide Profile of Neonatal Rat Brain Studied by TOF-SIMS Imaging
Open AccessReview

Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease

1
Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia
2
Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow 143025, Russia
3
Faculty of Medicine, School of Medical Sciences, University of New South Wales, Kensington, Sydney, NSW 2052, Australia
4
School of Medicine, University of Western Sydney, Campbelltown, Sydney, NSW 2560, Australia
5
Laboratory of Medical Genetics, Russian Cardiology Research and Production Complex, Moscow 121552, Russia
6
Department of Medical Nanobiotechnology, Pirogov Russian State Medical University, Moscow 117997, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2014, 15(7), 12807-12841; https://doi.org/10.3390/ijms150712807
Received: 11 May 2014 / Revised: 29 June 2014 / Accepted: 3 July 2014 / Published: 21 July 2014
(This article belongs to the Special Issue Bioactive Lipids and Lipidomics)
In atherosclerosis; blood low-density lipoproteins (LDL) are subjected to multiple enzymatic and non-enzymatic modifications that increase their atherogenicity and induce immunogenicity. Modified LDL are capable of inducing vascular inflammation through activation of innate immunity; thus, contributing to the progression of atherogenesis. The immunogenicity of modified LDL results in induction of self-antibodies specific to a certain type of modified LDL. The antibodies react with modified LDL forming circulating immune complexes. Circulating immune complexes exhibit prominent immunomodulatory properties that influence atherosclerotic inflammation. Compared to freely circulating modified LDL; modified LDL associated with the immune complexes have a more robust atherogenic and proinflammatory potential. Various lipid components of the immune complexes may serve not only as diagnostic but also as essential predictive markers of cardiovascular events in atherosclerosis. Accumulating evidence indicates that LDL-containing immune complexes can also serve as biomarker for macrovascular disease in type 1 diabetes. View Full-Text
Keywords: atherosclerosis; atherogenesis; immune complexes; low-density lipoproteins; inflammation atherosclerosis; atherogenesis; immune complexes; low-density lipoproteins; inflammation
Show Figures

Figure 1

MDPI and ACS Style

Orekhov, A.N.; Bobryshev, Y.V.; Sobenin, I.A.; Melnichenko, A.A.; Chistiakov, D.A. Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease. Int. J. Mol. Sci. 2014, 15, 12807-12841. https://doi.org/10.3390/ijms150712807

AMA Style

Orekhov AN, Bobryshev YV, Sobenin IA, Melnichenko AA, Chistiakov DA. Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease. International Journal of Molecular Sciences. 2014; 15(7):12807-12841. https://doi.org/10.3390/ijms150712807

Chicago/Turabian Style

Orekhov, Alexander N.; Bobryshev, Yuri V.; Sobenin, Igor A.; Melnichenko, Alexandra A.; Chistiakov, Dimitry A. 2014. "Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease" Int. J. Mol. Sci. 15, no. 7: 12807-12841. https://doi.org/10.3390/ijms150712807

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop